This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...

Explore how AI transforms cancer drug discovery by predicting proteins and accelerating drug candidate identification and ...

Research Institute today announced they have entered into an agreement with Janssen Research & Development, LLC, a Johnson & ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks ®, a data insights tool powered by the bfLEAP™ platform. BullFrog Data Networks ® evaluate high ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...